Embla Medical hf (OCSE:EMBLA) Additional Paid-In Capital : kr608 Mil(As of Mar. 2024)

View and export this data going back to 2009. Start your Free Trial

What is Embla Medical hf Additional Paid-In Capital?

Embla Medical hf's quarterly additional paid-in capital declined from Sep. 2023 (kr430 Mil) to Dec. 2023 (kr420 Mil) but then increased from Dec. 2023 (kr420 Mil) to Mar. 2024 (kr608 Mil).

Embla Medical hf's annual additional paid-in capital declined from Dec. 2021 (kr466 Mil) to Dec. 2022 (kr431 Mil) and declined from Dec. 2022 (kr431 Mil) to Dec. 2023 (kr420 Mil).

Embla Medical hf Additional Paid-In Capital Historical Data

The historical data trend for Embla Medical hf's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Embla Medical hf Additional Paid-In Capital Chart

Embla Medical hf Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Additional Paid-In Capital

Get a 7-Day Free Trial

490.90

428.55

465.78

431.42

420.20

Embla Medical hf Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Additional Paid-In Capital	Get a 7-Day Free Trial															427.41	422.48	429.60	420.20	608.02

Embla Medical hf Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital

(Issue Price

Par Value)

Shares Outstanding (Diluted Average)

Embla Medical hf Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Embla Medical hf's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Embla Medical hf (OCSE:EMBLA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Embla Medical hf (OCSE:EMBLA) » Definitions » Additional Paid-In Capital

Comparable Companies

Traded in Other Exchanges

OSSFF:USA OSSUY:USA

Address

Grjothals 5, Reykjavik, ISL

Website

https://www.ossur.com

Ossur hf is engaged in the design, development, manufacture, and sale of prosthetics and bracing & support products. The company's products improve mobility through technologies in the field of braces, supports, prosthetic limbs, and compression therapy. Its segments are the Bracing & Supports and Prosthetics segment. The bracing & support products are used to support joints and other body parts for therapeutic and preventative purposes. The Prosthetics segment includes artificial limbs and related products for individuals born without limbs. Its geographical segments are the Americas; Europe, the Middle East & Africa (EMEA); and the Americas & Asia-Pacific (APAC), of which the Americas generate nearly half of the company's revenue.

Embla Medical hf (OCSE:EMBLA) Headlines

No Headlines